Fund Holdings — BML Capital Management, LLC

Total Portfolio Value:
$160.97M
Total Bought:
$39.07M
Total Sold:
$34.65M
Net Transaction:
+$4.42M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Aclaris Therapeutics, Inc.(ACRS)14,250,00014,250,0000$16.39M$35.34M21.95%+$18.95M
Ishares Tr0 3 MNTH TREASRY
0-3 MTH TREASURY
270,000260,000-10,000$27.19M$26.08M16.20%-$1.11M
Atea Pharmaceuticals, Inc.(AVIR)6,650,0007,608,312+958,312$22.28M$25.49M15.83%+$3.21M
Adverum Biotechnologies Inc2,268,0642,268,0640$15.92M$10.59M6.58%-$5.33M
An2 Therapeutics Inc5,749,4325,749,4320$6.15M$7.93M4.93%+$1.78M
Instil Bio, Inc.(TIL)335,000400,000+65,000$22.55M$7.64M4.74%-$14.92M
Essa Pharma Inc04,221,546+4,221,546$0$7.56M4.69%+$7.56M
Whitehawk Therapeutics, Inc.(WHWK)2,000,0002,100,000+100,000$4.12M$6.63M4.12%+$2.51M
Oramed Pharmaceuticals Inc.(ORMP)2,186,1912,643,907+457,716$5.33M$6.40M3.97%+$1.06M
Ikena Oncology Inc723,2883,585,866+2,862,578$1.25M$5.88M3.65%+$4.63M
PMV Pharmaceuticals, Inc.(PMVP)1,688,7723,466,684+1,777,912$2.52M$5.23M3.25%+$2.72M
Achilles Therapeutics PlcADS4,100,0024,100,0020$4.18M$4.67M2.90%+$492.0K
Connect Biopharma Hldgs LtdADS2,093,2322,093,2320$3.01M$2.89M1.79%-$125.4K
Milestone Pharmaceuticals Inc.(MIST)1,136,0911,136,0910$1.73M$2.68M1.67%+$954.3K
Athira Pharma Inc02,775,885+2,775,885$0$1.63M1.01%+$1.63M
Astrotech Corp220,410220,4100$1.76M$1.48M0.92%-$279.9K
Lisata Therapeutics, Inc.(LSTA)284,669284,6690$854.0K$848.3K0.53%-$5.7K
Palvella Therapeutics, Inc.(PVLA)042,130+42,130$0$505.6K0.31%+$505.6K
Vistagen Therapeutics, Inc.(VTGN)150,000150,0000$451.5K$442.5K0.27%-$9.0K
Kezar Life Sciences Inc
COM NEW
048,668+48,668$0$327.0K0.20%+$327.0K
LENZ Therapeutics, Inc.(LENZ)60,0009,271-50,729$1.42M$267.7K0.17%-$1.16M
Nextcure Inc276,465273,536-2,929$378.8K$210.9K0.13%-$167.9K
Verrica Pharmaceuticals Inc.(VRCA)180,000174,651-5,349$261.0K$122.3K0.08%-$138.7K
Allovir Inc603,086184,246-418,840$487.6K$77.4K0.05%-$410.2K
Hillevax Inc19,76020,760+1,000$34.8K$43.0K0.03%+$8.2K
Forte Biosciences Inc70,4680-70,468$393.9K$0—-$393.9K
CalciMedica, Inc.(CALC)153,8870-153,887$681.7K$0—-$681.7K
Pieris Pharmaceuticals Inc42,1300-42,130$698.5K$0—-$698.5K
Reneo Pharmaceuticals Inc3,457,3950-3,457,395$5.88M$0—-$5.88M
Spdr Ser TrBLOOMBERG 1 3 MO
ST STR BLO 1 ETF
175,0000-175,000$16.07M$0—-$16.07M
Talis Biomedical Corp248,7020-248,702$460.1K$0—-$460.1K
Tectonic Therapeutic, Inc.(TECX)211,7520-211,752$6.42M$0—-$6.42M
Vanda Pharmaceuticals Inc.(VNDA)228,5000-228,500$1.07M$0—-$1.07M
Page 1 of 1
BML Capital Management, LLC — 13F Holdings — Q4 2024 | TickerTrail